Ramit Singla
Neurology with Special Qualifications in Child Neurology · Columbia, SCNPI 1427586908
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,339 of the $1,497 with a category attached, or 89.4%. 15 manufacturers reported payments, led by AstraZeneca at 29.3% of the total. Reporting peaked in 2022 at $545 and has fallen 64.9% since, to $191 in 2025.
Across 28 payments — averaging $53.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$439
- UCB, Inc.$197
- Medtronic$135
- CSL Behring$123
- Eisai Inc.$118
- Kyowa Kirin, Inc.$106
- plus $380 from 9 others
What the payments were for
- Food & beverage$1,33989%
- Education$15811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $439 |
| UCB, Inc. | 7 | $197 |
| Medtronic | 1 | $135 |
| CSL Behring | 1 | $123 |
| Eisai Inc. | 2 | $118 |
| Kyowa Kirin, Inc. | 1 | $106 |
| Sanofi | 1 | $95 |
| Neurelis, Inc. | 2 | $92 |
| Chiesi USA, Inc. | 1 | $92 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| AbbVie | 1 | $18 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,497 in reported general payments places this provider in the 75th percentile of 25 neurology with special qualifications in child neurology providers in South Carolina.
See all neurology with special qualifications in child neurology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology with special qualifications in child neurology in Columbia
- Rebecca LehmanColumbia$7K
- Mary GregoryColumbia$783
- Jordann StaplesColumbia$562
- Matthew KhayataColumbia$423
- Krisztina Harsanyi-JillingColumbia$255
- James ParrottColumbia$54
- Dalila LewisCharleston$113K
- Mariana SzuchmacherCharleston$7K
- Robert TurnerCharleston$2K
- Michael BabcockGreenville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.